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MtDNA mutagenesis impairs elimination of
mitochondria during erythroid maturation leading
to enhanced erythrocyte destruction
K.J. Ahlqvist1, S. Leoncini2,3, A. Pecorelli2,3, S.B. Wortmann4, S. Ahola1, S. Forsstro¨m1,
R. Guerranti5, C. De Felice6, J. Smeitink4, L. Ciccoli2, R.H. Ha¨ma¨la¨inen1 & A. Suomalainen1,7,8
Haematopoietic progenitor cells show special sensitivity to mitochondrial DNA (mtDNA)
mutagenesis, which suggests that increased mtDNA mutagenesis could underlie anemias.
Here we show that elevated mtDNA mutagenesis in mice with a proof-reading deﬁcient
mtDNA polymerase (PolG) leads to incomplete mitochondrial clearance, with asynchronized
iron loading in erythroid precursors, and increased total and free cellular iron content.
The resulting Fenton chemistry leads to oxidative damage and premature destruction of
erythrocytes by splenic macrophages. Our data indicate that mitochondria actively contribute
to their own elimination in reticulocytes and modulate iron loading. Asynchrony of this
sequence of events causes severe mitochondrial anaemia by depleting the organism of red
blood cells and the bone marrow of iron. Our ﬁndings account for the anaemia development
in a progeroid mouse model and may have direct relevance to the anemias associated with
human mitochondrial disease and ageing.
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M
itochondrial dysfunction leads to a plethora of human
diseases with variable manifestations and age of onset,
with anaemia being a severe manifestation in a subset of
these disorders1,2. Pearson’s syndrome is a sporadic infant-onset
mitochondrial disorder caused by a heteroplasmic mitochondrial
DNA (mtDNA) deletion and characterized by severe anaemia.
This multi-organ disorder is often fatal during early years of
life3,4. These patients have been reported to have vacuolization
of bone-marrow precursors4, but the pathogenic mechanisms of
Pearson’s anaemia are unknown. Some patients recover from the
blood manifestation after the ﬁrst years of life along with the
loss of mtDNA deletion in leucocytes4. Similar to patients with
Pearson’s syndrome, mice carrying a heteroplasmic primary
single mtDNA deletion (Mitomice) develop anaemia and kidney
dysfunction, and die at 6 months of age5,6. Anaemia is also a
manifestation of the progeroid mtDNA mouse model known as
the ‘Mutator’, which harbours a proof-reading deﬁcient mtDNA
polymerase gamma (PolG) that leads to increased random
mtDNA mutagenesis in all cell types, including somatic stem
cells (SSCs)7–9. These mice show aberrant hematopoiesis that
initiates in embryogenesis and is progressive, developing anaemia
and leucopenia after 6 months of age ultimately restricting their
lifespan to about 50 weeks of age9. However, even on terminal-
stage anaemia the Mutator bone marrow contains all the different
erythroid progenitor populations and the total cellularity is not
decreased9,10. Therefore, exhaustion of the haematopoietic stem
cell (HSC) pool does not account for the severe anaemia of these
mice.
The Mitomice and Mutators are the only mouse models with
constitutive mitochondrial dysfunction that manifest with
anaemia. Why the haematopoietic compartment is spared in
other human mitochondrial disorders and mouse models is
currently unknown. Several hypotheses could account for the
effect: (1) the causative mtDNA mutation is selected against in
proliferating cells, as occurs in Pearson syndrome patients that
survive the anaemia; (2) mtDNA mutagenesis is slowly
progressive and/or does not affect the erythroid cells (adult-onset
mtDNA maintenance disorders) (3) the speciﬁc mitochondrial
pathway is redundant11,12. For example, Deletor mice12 carry a
mutation in the nuclear-encoded replicative Twinkle helicase,
leading to subtle progressive accumulation of secondary multiple
mtDNA deletions after 1 year of age. These mice only show
mtDNA mutagenesis in postmitotic tissues, not in SSCs, and
accordingly do not develop anaemia9.
Mitochondria are required for haeme biosynthesis and thus
critical in the key maturation steps of the erythroid lineage. When
the haemoglobin synthesis reaches a threshold the erythrocyte
precursors enucleate, and the immature erythrocytes—the
reticulocytes—exit the bone marrow and enter the blood
circulation. The ﬁnal maturation of the erythrocytes, including
clearance of the remaining organelles and the transferrin receptor
(TfR), occurs in the peripheral blood. Mitochondrial removal
from maturing erythrocytes occurs by degradation13–15 the
signalling of which is only starting to be unravelled. Mitophagy
in erythroid maturation depends on Atg7 or Unc-51-like kinase 1
(Ulk1)-dependent pathways15–17 with the latter suggested to be
most important for mitophagy in foetal deﬁnitive reticulocytes18.
BCL2-related protein NIX (BNIP3L) has been shown to mark
mitochondria for mitophagy19,20, and to be important for the
known macroautophagic mechanisms of mitochondrial clearance.
The active destruction of mitochondria renders the mature red
blood cells completely devoid of the organelles.
Removal of oxygen metabolizing mitochondria from iron-
loaded erythrocytes is essential to prevent oxidative damage in
mature erythrocytes. Typically in biological systems iron is
protein bound21, in a reduced state, which is required for haeme
biosynthesis and oxygen binding22. However, in pathological
conditions, such as those inducing superoxide production from
the mitochondrial respiratory chain (RC), iron can be released
from protein complexes or cofactors, including haeme23.
Free iron is highly reactive with oxygen, and leads to a vicious
circle of reactive oxygen species (ROS) generation by Fenton
reaction. The free redox-active, non-protein-bound iron (NPBI)
further promotes oxidative stress by oxidating, for example,
polyunsaturated fatty acids of the membranes, creating reactive
aldehydes, including 4-hydroxy-2-nonenal (4-HNE)23,24. 4-HNE
forms stable adducts with amino acid residues cysteine, histidine
and lysine, thereby modifying protein function25. Moreover, in
erythrocytes, oxidative damage can impair ﬂippase activity
required to sequester phospholipid phosphatidylserine (PS) to
the inner monolayer of the cell membrane26,27. Exposure of PS on
the erythrocyte surfaces acts as a signal for splenic macrophages
to capture and destroy old erythrocytes28 thereby contributing to
anaemia.
In addition to the damaging effects of oxidative stress, ROS,
especially H2O2, are an important source of signalling
molecules for HSC fate determination and differentiation29–32.
In Mutators, the redox-active antioxidant N-Acetyl-L-cysteine
(NAC) rescued the erythroid and lymphoid differentiation in
embryonal haematopoiesis, indicating that subtle increases
in ROS signalling by mtDNA mutagenesis disturbed SSC
homoeostasis9.
We show that elevated mtDNA mutagenesis impairs erythro-
cyte maturation by delaying mitochondrial and TfR clearance,
increasing free iron, erythrocyte lipid oxidation and membrane
modiﬁcation, which altogether shortens the lifespan of the
erythrocytes because of their accelerated destruction in the
spleen. Our results suggest that mitochondria have an active role
in their own removal from maturing erythrocytes, and based on
these ﬁndings we propose a novel mechanism for mitochondrial
anaemia.
Results
Mutator blood contains erythrocytes carrying mitochondria.
At 11 months of age, Mutator mice developed terminal anaemia,
with blood haemoglobin content as low as 50 g l 1, with a sig-
niﬁcant proportion of bone-marrow erythroid precursors show-
ing an abnormal precursor identity9,10. At this age, the Mutators
showed increased reticulocyte amounts in their peripheral blood,
a feature consistent with severe anaemia (Mutator 7.4±2.6% of
total erythrocytes, n¼ 11; wild type (WT) 3.3±0.6%, n¼ 11;
Po0.0001, Student’s t-test). However, these reticulocytes were
immature (Fig. 1a) and had fourfold increased content of TfR and
eightfold increased content of mitochondria (Fig. 1b,c).
The ﬂow cytometric analysis showed that a subset of mature
erythrocytes of the Mutator mice had no or few ribosomes, but
contained mitochondria (Fig. 1d red box), which was further
veriﬁed by electron microscopy of the Mutator peripheral
blood (Fig. 1e). This was never observed in the WT mice.
In the biconcave erythrocytes carrying mitochondria, 9%
of the organelles were surrounded by autophagic membranes
(Supplementary Fig. 1). This suggested that mitophagy per se was
slowed down in the Mutators or that a decreased number of
mitochondria were marked for clearance. We also observed in the
electron microscopic analysis of the Mutator erythrocytes the
presence of electron-dense cytoplasmic speckles, more dense
than ribosomes, reminiscent of metal accumulation. These
features were not observed in WT mature biconcave erythrocytes.
Together these data suggest that elevated mtDNA mutagenesis
severely disturbs mitochondrial degradation during erythroid
maturation.
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Mutator reticulocytes have delayed mitochondrial clearance.
To study in detail the impact of mtDNA mutagenesis on ery-
throid maturation, we established in vitro analysis of Mutator
bone-marrow HSCs on methylcellulose. This indicated that their
erythroid differentiation was signiﬁcantly delayed, but not com-
pletely stalled (Fig. 2a). The typical reddish, haemoglobin-con-
taining erythroid progenitor colonies were apparent in Mutator
samples only after 12 days of culture, whereas WT HSCs formed
colonies already in a week (Fig. 2b). We then established reti-
culocyte culture to investigate the dynamics of erythroid
maturation, especially focusing on mitochondrial degradation.
We stimulated reticulocytosis by serial phlebotomy in young, pre-
anaemic Mutators, and cultured the reticulocytes in vitro. Both
Mutator and WT mice produced large amounts of reticulocytes
(Mutator: 13.8±1.1%, n¼ 5; WT: 14.7±0.7%, n¼ 5), indicating
similar capacity of their bone marrow for stress-induced
erythropoiesis. However, the Mutator reticulocytes showed
signiﬁcantly delayed mitochondrial removal (Fig. 2c), whereas
ribosomal RNA clearance was similar to WT (Supplementary
Fig. 2a). Three days post harvest, only 4.3±0.6% of WT erythroid
cells contained mitochondria, whereas 9.3±1.4% of the Mutators
still had mitochondria (P¼ 0.0003, Student’s t-test) (Fig. 2d).
Ultrastructural analysis of the blood after the serial phlebotomy
conﬁrmed in the Mutators the presence of morphologically
mature biconcave erythrocytes containing mitochondria, while in
the WT the only mitochondria-containing cells were round in
shape, a feature typical for early reticulocytes (Supplementary
Fig. 2b). The WT reticulocyte mitochondria lost their membrane
potential rapidly in culture followed by organelle disappearance,
but Mutators retained mitochondria with membrane potential
signiﬁcantly longer (2 days of culture: WT: 7.9±0.6%, n¼ 4;
Mutator: 13.4±2.2%, n¼ 5, P¼ 0.01, Student’s t-test) (Fig. 2e).
Lysosomes, involved in autophagic clearance, were similar in
number in Mutator reticulocytes compared with WT cells
(LysoTracker Reds positive cells: WT 2.7±1.4%, Mutator
2.2±0.7%), whereas the protein level of NIX was reduced
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Figure 1 | Erythrocytes carry mitochondria in mitochondrial DNA mutator mouse. (a) Reticulocyte maturity staged by ribosomal RNA content (thiazole
orange) in the peripheral blood at the age of 11 months. Mutator (mut) mice showed an increased proportion of immature reticulocytes (two-tailed
Po0.0001, Student’s t-test). Age 6 months: WT n¼ 5, Mutator n¼4; age 11 months: WT n¼ 11, Mutator n¼ 11 (30,000 cells per sample were analyzed).
(b) Representative FACS plot and (c) quantiﬁcation of transferrin receptor (TfR) amount and mitochondria (MitoTracker Green) in Mutator erythrocytes at
the age of 11 months (two-tailed Po0.0001 and P¼0.0059, respectively, Student’s t-test). WT: n¼ 12, Mutator: n¼ 8 (30,000 cells per sample were
analyzed). Data are presented as mean±s.d. (d) A representative FACS plot of ribosomes (thiazole orange, TO) and mitochondria (MitoTracker Red); black
box: reticulocytes positive for both TO and MTR; red box: abnormal population carrying mitochondria. (e) Electron micrograph of peripheral blood
erythrocytes at 8 months of age. WT erythrocytes: biconcave morphology, no organelles; Mutator erythrocytes (three separate ﬁgures) contained
mitochondria (arrows). WT scale bar, 1 mm, Mutator scale bar, 0.5 mm. See also Supplementary Fig. 1.
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(Supplementary Fig. 2c). These results indicate that mtDNA
mutagenesis affects erythrocyte maturation by delaying mito-
chondrial exclusion in reticulocytes, and that mitochondrial sig-
nalling contributes to their own exclusion.
Antioxidant is unable to rescue the mitochondrial clearance.
Previously, we showed that NAC supplementation rescued ery-
throid differentiation in Mutator-mouse embryos9, and therefore
we tested whether NAC could affect the maturation and
organellar exclusion in Mutator reticulocytes. We administered
NAC to Mutators and WT during phlebotomy and reticulocyte
culture, but found no effect on mitochondrial clearance (Fig. 2d).
NAC signiﬁcantly accelerated mitochondrial depolarization in
Mutator reticulocytes (Fig. 2e), but did not affect lysosomal
content (LysoTracker positive cells: WT 2.7±1.4%, WT NAC
2.8±0.8%, Mutator 2.2±0.7%, Mutator NAC 2.0±0.7%), or
increase the amount of NIX protein (Supplementary Fig. 2c).
These results indicate that ROS/redox signalling is not mediating
the mitochondrial removal defect in Mutators, or at least
acutely administered NAC is unable to rescue mitochondrial
clearance.
W
ild
 ty
pe
W
ild
 ty
pe
 N
AC
c
1 30 2 Days
10
15
5
%
20
Cells with mitochondria
Amount of BFU-E coloniesa
5
0
15
10
Co
lo
ni
es
7 12 Days
****
****
***
WT
mut
b Maturation of BFU-Es
7 12 Days
WT
mut
****
Co
lo
ni
es
10
0
5
d e
10
WT
Mutator
WT NAC
Mutator NAC 15
5
%
20
10 2 Days
***
**
**
*
*
Polarized mitochondria
*
Day 0 Day 3 Day 0 Day 3
M
ut
at
or
M
ut
at
or
 N
AC
Figure 2 | Delayed erythroid maturation and mitochondrial clearance in vitro. (a) Colony forming assay for bone-marrow hematopoietic stem cells
(Mutator: n¼ 8, WT: n¼8, each sample analyzed in triplicate). Mutators showed decreased amount of BFU-E (burst-forming unit, erythroid) colonies
(two-tailed Po0.0001, Student’s t-test, data are presented as mean±s.d.). (b) Time required to form haemoglobin-containing mature BFU-Es was delayed
by 5 days in Mutators compared with WT (Po0.0001, linear regression analysis). (c) Confocal microscopy of cultured reticulocytes from phlebotomized
animals with or without NAC treatment: polarized (TMRM in red) and depolarized (MitoTracker Green) mitochondria. Mutator reticulocytes retained
mitochondria longer than WTcells; part of the mitochondria were still polarized after 3 days of culture (arrowheads). Scale bars, 10mm. (d) Quantiﬁcation
of cells with mitochondria (FACS analysis, MTG per total cell count): Mutator reticulocytes retained mitochondria signiﬁcantly longer than WT, and NAC
had no effect on the clearance (WT versus Mutator day 1 P¼0.004, day 2 P¼0.002 and day 3 P¼0.0003, Student’s t-test). (e) Quantiﬁcation of cells
with polarized mitochondria (FACS analysis, TMRM per total cell count): NAC increased depolarization of mitochondria in Mutator reticulocytes (WT
versus Mutator P¼0.01, Mutator versus Mutator NAC day 2 P¼0.03). For (d,e) WT: n¼4, Mutator: n¼ 5, WT NAC: n¼ 6 and Mutator NAC: n¼ 6
(30,000 cells per sample were analyzed). Data are shown as mean±s.d.
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Mutators develop anaemia despite long-term NAC treatment.
To test whether NAC treatment could promote erythrocyte
maturation, if administered through development and adult life of
Mutators in vivo, we performed a long-term NAC treatment trial:
Mutators and WTmice were supplemented with NAC, throughout
embryogenesis until 11 months of adult age. In contrast to the
NAC rescue of the embryonal HSC defect9, NAC had no effect on
the adult Mutator erythropoiesis defect (Supplementary Fig. 2e,f).
A similar amount of peripheral blood erythrocytes with
mature morphology contained mitochondria in NAC-treated
versus non-treated Mutator animals, and 9% of mitochondria
were surrounded by autophagic membranes in both groups
(Supplementary Fig. 1). These results indicate that mitochondrial
ROS/redox signalling contributes differently to haematopoiesis and
erythroid differentiation during embryonal and adult life.
Mutators show aberrant iron loading and oxidative stress. Flow
cytometric analysis showed that in addition to mitochondrial
presence, iron loading was potentially abnormal: most of the
Mutator reticulocytes that retained mitochondria were also TfR
positive (Fig. 1b,c). Furthermore, in cultured Mutator reticulo-
cytes, TfR localization was abnormal being dispersed throughout
the cell membrane and consistent with extended TfR-mediated
iron loading. In contrast, in WT reticulocytes the TfR were
clustered for exclusion (Fig. 3a). NAC treatment rescued the
localization of TfR in Mutator cells to be similar to WT (Fig. 3a).
Extended presence of TfR within the Mutator reticulocytes sug-
gested abnormal iron loading, and indeed, we found the total iron
content of Mutator serum as well as transferrin saturation to be
signiﬁcantly increased (Fig. 3b,c). Furthermore, free NPBI was
increased over twofold in Mutators at the age of 8–10 months,
both in erythrocytes (Po0.001, Student’s t-test) and plasma
(Po0.0001, Student’s t-test) (Fig. 3d). Free iron is highly reactive
with oxygen, and a potent source of ROS. To test for oxidative
stress in erythrocytes, we measured 4-HNE protein adducts as
indicators of lipid peroxidation to be 1.7-fold increased in the
erythrocyte membranes (Fig. 3e) and in plasma (WT: 15±1 a.u.,
n¼ 6; Mutator: 19±2 a.u. n¼ 8; P¼ 0.0013, Student’s t-test).
These results show that mitochondrial exclusion and TfR-medi-
ated iron loading are both affected in Mutator reticulocyte
maturation and suggest that mitochondrial ROS/redox signalling
guides the timing of transferrin-mediated iron loading.
Furthermore, the asynchronized TfR-mediated iron loading
results in an increase of free cellular iron and extensive oxidative
damage in Mutator erythrocytes.
Mutator erythrocytes are prematurely captured and destroyed.
Oxidative damage on erythrocytes is a signal for spleen macro-
phages to capture the old cells from blood circulation for
degradation. Such signal is produced by PS exposure on ery-
throcyte membrane outer leaﬂet, resulting from oxidative damage
in the enzymes maintaining PS asymmetry. We found that at the
age of 8–10 months, Mutator peripheral blood erythrocytes
showed a remarkable10-fold increase in PS exposure (P¼ 0.001,
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reticulocytes (Ter119 green) at the second day of culture analyzed by
confocal microscopy. WT reticulocytes: most of the TfR was clustered
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adducts, lipid peroxidation-induced protein damage, in the erythrocyte
membranes at 8–10 months of age (two-tailed Po0.0001, Student’s t-test).
Representative Western blots shown on left and quantiﬁcation on right
(WT: n¼ 7, mut: n¼ 5, three to ﬁve animals were pooled in each sample).
For b–e, data are shown as mean±s.d.
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Student’s t-test) (Fig. 4a and Supplementary Fig. 3a). The Mutator
spleens harboured a 1.9-fold higher amount of erythroid cells
than the WT (Po0.0001, Student’s t-test) (Fig. 4b), consistent
with extra-medullary haematopoiesis described in these animals8,
but these cells showed a 5.5-fold increase in PS exposure
(Po0.0001, Student’s t-test) (Fig. 4c and Supplementary
Fig. 3a), indicating an increased amount of aged erythrocytes in
the spleen. Furthermore, the amount of active splenic
macrophages (CD45þ , mac3þ ) that capture damaged
erythrocytes for destruction, was twofold in Mutators, when
compared with WT (P¼ 0.0001, Student’s t-test) (Fig. 4d), and
the macrophages were loaded with iron (Fig. 4e). These data
indicate enhanced splenic destruction of erythrocytes. However,
the Mutator bone marrow showed very low iron amount (Fig. 4f).
These ﬁndings suggested premature aging and shortened lifespan
of the Mutator erythrocytes. To assess the lifespan directly, we
biotin-labelled the circulating erythrocytes of moderately anaemic
6-month-old Mutators, and monitored their clearance for 3
weeks. Indeed, the Mutator erythrocytes showed signiﬁcantly
decreased lifespan compared with WT littermates (P¼ 0.03,
linear regression analysis) (Fig. 4g). Furthermore, Mutator
peripheral blood and spleen erythrocytes showed increased
levels of CD47 (Supplementary Fig. 3b), suggesting that the
circulating Mutator erythrocytes were newly formed. These
results suggest that Mutator erythrocytes aged prematurely and
were degraded soon after their release from the bone marrow.
The extensive destruction of erythrocytes in the spleen depleted
bone marrow of iron, which further exacerbated the anaemia.
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Human Pearson’s anaemia shares similar maturation defect.
As mtDNA mutagenesis induced anaemia in mice, we asked the
question whether the pathogenesis was similar in human patients
with anaemia due to mtDNA mutation. To test this idea, we
obtained a rare blood sample from a 22-month old girl suffering
from Pearson’s syndrome in acute anaemic state. She showed
reticulocytosis, with 4.5-fold increased amount of reticulocytes
(Fig. 5a, dashed boxes), as a compensatory mechanism for
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anaemia. Similar to the Mutator-mouse model, a subset of mature
erythrocytes contained mitochondria, but were devoid of ribo-
somes (Fig. 5a, red boxes). Electron microscopic analysis showed
that a subset of peripheral erythrocytes possessed an abnormal
membrane structure (Fig. 5b) and mitochondria. This Pearson’s
syndrome patient spontaneously recovered from the anaemia,
after which no abnormal cells with organelles were found, either
by ﬂuorescence-activated cell sorting (FACS) analysis (Fig. 5a
solid box) or by electron microscopy (Fig. 5b). These results
suggest that Pearson’s syndrome anaemia is associated with an
erythroid maturation defect with delayed mitochondrial clear-
ance, highly similar to the ﬁndings we observed in the Mutator-
mouse model.
Discussion
We report here molecular mechanisms of mtDNA mutagenesis-
associated anaemia. We show that mtDNA mutagenesis affects
mitochondrial removal during erythroid development indicating
that signals intrinsic to mitochondria contribute to red blood cell
maturation. The consequence of mtDNA mutagenesis is
respiratory chain enzymes carrying random single amino acid
changes, resulting in subtle increase of ROS9,33. We show that
ROS/redox signalling in erythroid maturation affects transferrin-
mediated iron loading that in turn leads to an increase of total
and NPBI in the peripheral blood of these animals. The presence
of free iron in oxygen-carrying red blood cells is exceptionally
deleterious, leading to a vicious cascade of oxidative damage and
modiﬁed membrane lipid structure—even after mitochondria
were successfully excluded. We show that newly synthesized red
blood cells in the progeroid Mutator-mouse model carry a
membrane signature of premature aging that leads to premature
splenic capture and shortened lifespan of the erythrocytes. This
process results in iron accumulation in the spleen with
simultaneous iron deﬁciency in the bone marrow, despite
normal nutritional iron intake. This evidence suggests that
mtDNA mutagenesis induces cell-intrinsic aberration to
mitochondrial removal and a major iron metabolic defect,
within erythroid progenitors as well as in bone marrow and
spleen. The mechanisms we have identiﬁed may be relevant to the
manifestation of anemias in human mitochondrial disorders as
well as those of old age where the decline in mitochondrial
function and increased mtDNA mutagenesis are well
documented.
We show here that mitochondria regulate their own removal
from maturing reticulocytes. Delayed mitochondrial clearance
has been found in mouse models that are missing speciﬁc
components of mitochondrial clearance pathway, including
Nix19,20, Ulk1 (ref. 17) and Atg7 (refs 34,35). Reticulocyte
culture from those knock-out animals mimicked closely the
mitochondrial exclusion defect we observed in the
Mutators15,17,20. Furthermore, pharmacological inhibition of 15-
lipoxygenase (15-LOX), an enzyme involved in degradation of
mitochondria during reticulocyte maturation, led to an
accumulation of mitochondria in a subset of mature
erythrocytes13,36. Nonetheless, in all of these murine models the
majority of the mature erythrocytes lacked mitochondria,
suggesting considerable functional redundancy in organelle
clearance during erythroid development. The Mutator mouse—
a model affecting primarily mtDNA quality and not directly
mitophagy-associated proteins—indicates that mitochondrial-
originating signals can modify organellar exclusion.
We found that the mitochondrial exclusion delay in Mutator
in vitro reticulocytes was accompanied by a delay in mitochon-
drial depolarization, which was rescued by NAC, indicating that
ROS/redox status participates in loss of membrane potential in
erythroid maturation. In reticulocytes, depolarized mitochondria
most often reside within autophagosomes, but depolarization is
not thought to be required for mitophagy35. We did not ﬁnd
direct evidence for NAC-induced autophagy or lysosomal bio-
genesis, to explain NAC-enhanced mitochondrial uncoupling.
This suggests that mitochondrial depolarization was not a direct
consequence of mitophagy, and that mtDNA mutagenesis
associated with decreased capacity to mitophagy, agreeing with
a previous report37. In non-erythroid cells, mitophagy has been
induced by chemical uncoupling of mitochondria, by
mechanisms involving Pink1–Parkin-mediated pathway and
Ulk1 (refs 38–40). Whether similar mechanisms regulate
mitophagy during erythrocyte maturation remains to be explored.
We show that the prolonged presence of mitochondria in
erythrocytes is accompanied by severe aberration of iron
metabolism, delayed TfR clustering and exclusion, suggesting
that mitochondrial-derived signals contribute to these mechan-
isms. The remarkable increase of both total and free iron, inside
erythrocytes and in plasma, strongly supported extended iron
loading, leading to extensive oxidative stress and damage of
erythrocyte membranes in Mutators. Consistently, oxidative
membrane aging-markers in the newly formed red blood cells
were increased, indicating premature aging of Mutator erythro-
cytes. Similar ﬁndings of increased oxidative stress and enhanced
erythrocyte destruction have been reported in disorders of iron
metabolism, as well as in sickle cell anaemia41,42. Mutator mice
were originally not found to have oxidative damage in their
postmitotic tissues7,43, but recent reports indicated some increase
of damage44, as well as age-dependent increase of hydrogen
peroxide33. In SSCs of Mutators, subtle increase of ROS has been
shown to modify signalling and cause SSC dysfunction9. Our
results show that even in an organism with wide-spread mtDNA
mutagenesis in all tissues, ROS signalling and oxidative stress can
affect function of a very speciﬁc cell type. In the Mutator, the
iron-mediated oxidative radicals and damage have deleterious
effects to red blood cell maturation, limiting the lifespan of the
animals.
We propose here a pathomechanistic model for mtDNA
mutagenesis-linked anaemia (Fig. 5c). As both mitochondria and
TfR-mediated iron loading are simultaneously required for haeme
synthesis, and the removal of both mitochondria and TfR are
tightly regulated in erythroid cell maturation, these mechanisms
are likely to be synchronized. A previous report found that ROS
promoted translation of TfR thereby prolonging iron loading45.
We propose that the continued presence of mitochondria in
maturing erythroid cells is signalled to TfR through subtle ROS
signalling, and is magniﬁed by mtDNA mutagenesis. Therefore,
this elevated ROS signal leads to extended TfR activity and iron
loading in erythroid precursors that leads to an increase of
cellular iron with free oxidized—‘rusty’—iron unable to be
inserted to haeme or bind oxygen. These conclusions are
supported by the fact that NAC rescued TfR exclusion in
Mutator erythrocytes. NAC has also been shown to increase iron
regulatory protein-2 degradation, decreasing TfR activity46. The
accumulation of NPBI inevitably induces extensive oxidative
stress through Fenton reaction and leads to membrane damage
that triggers splenic macrophages to capture and destroy
circulating erythrocytes. Ultimately this vicious circle depletes
the organism of erythrocytes and sequesters iron away from the
bone marrow compromising erythropoiesis.
As the anaemia in Mutator-mouse anaemia mimicked
Pearson’s syndrome in humans, we searched from large clinical
centres treating mitochondrial disease patients for samples from
patients with acute Pearson’s anaemia. We were able to obtain
samples from one rare patient, in her acute anaemic phase as well
as after recovery, and showed that her peripheral erythrocytes
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contained mitochondria, similar to the Mutators. The rarity,
common lethality of the syndrome and transient nature of
Pearson’s anaemia hampered collection of a series of samples.
Our intriguing ﬁndings in a single Pearson’s patient were
consistent with the mechanism we established in mice with
elevated mtDNA mutations, suggesting the potential for a
common pathogenesis linking mitochondrial dysfunction to
anaemia. Furthermore, the decreased erythroid colony forming
potential of Mutator HSCs, combined with a severe maturation
delay, is also typical for HSCs extracted from aged people47.
Anaemia is an important class of human disorders affecting over
50% of 80-year-olds in the population48, but only 30% of aging-
related anaemia can be explained by iron deﬁciency49. Since
mtDNA mutations accumulate in normal aging humans50 this
raises the question whether aging-related anaemia in human
population might also have mitochondrial contribution. Our
ﬁndings from a progeroid mouse model anaemia suggest that
related ‘rusty-when-old’ mechanisms could be important for
pathogenesis of anaemia of old age.
Methods
Mouse models. All animal experimentation was approved by the Ethical Review
Board of Finland. Mutator mice with a knock-in inactivating mutation (D257A) in
the exonuclease domain of DNA polymerase gamma were used7. The strain was
maintained by crossings with D257A/wt males and wt/wt (B57BL/6JRcc) females to
prevent transmission of mtDNA mutations to germline. Experimental groups were
produced by crossings with F1 generation D257A/wt females and D257A/wt males.
The patient is the ﬁrst child of unrelated parents. She was born after normal
pregnancy, delivery and ﬁrst months of life. At the age of 8 months, after
respiratory infection, she developed severe anaemia with hypocellular bone
marrow. A single heteroplasmic mtDNA deletion of 6 kb in size was found, the
mutant mtDNA comprising about 70% of all mtDNA in peripheral blood cells. The
patient was dependent on erythrocyte transfusions until the age of 20 months. By
the age of 2 years, she had spontaneously recovered from the anaemia. Blood
samples were taken during the acute anaemia, 2 months after previous transfusion,
and a follow-up sample 15 months after the last transfusion. The control subject
was an age-matched patient with medium-chain acyl-coenzyme-A dehydrogenase
deﬁciency, a mitochondrial disease without anaemia. Informed consent was
obtained from the parents of the patient and control.
Terminal blood samples. Mice were killed and blood was collected into EDTA
tube (Greiner bio-one) by heart puncture. In the iron and 4-HNE-PA analysis, Li-
heparin tubes were used, and samples from —three to ﬁve animals were pooled
together to have enough sample for the analysis. Plasma and cells were separated by
centrifugation and plasma was used for NPBI and 4-HNE-PA analysis (see below).
Buffy coat was removed by aspiration and erythrocytes were washed twice with
0.9% NaCl. Half of packed red blood cells (RBCs) were used for NPBI analysis, and
RBC ghosts were made from the remaining packed cells (see below).
Blood count. Blood count was performed from whole blood samples during the
same day using Advia 2120i analyzer (Siemens).
Assessment of maturity of the reticulocytes. Intensity of ribosomal RNA
staining (thiazole orange, sc-215967, Santa Cruz) was used to stage reticulocytes as
immature (most intense thiazole orange (TO) signal), intermediate and mature
according to standard protocol51. Fluorescent signal was detected by Accuri ﬂow
cytometer (Becton Dickinson) and 30,000 cells per sample were analyzed. Male
mice were analyzed at the age of 6 and 11 months.
Morphological analysis of erythrocytes by electron microscopy. Lymphocytes
and erythrocytes were separated from EDTA blood using Ficoll-Paque Plus (GE
Healthcare) according to manufacturer’s instructions. Cells were ﬁxed with 5%
glutaraldehyde. Plastic embedding and sectioning were performed in the Electron
Microscopy Unit in Institute of Biotechnology (University of Helsinki, Finland).
Samples were analyzed using Jeol 1200 EX II transmission electron microscope.
Male mice were analyzed at the age of 8 months.
Induction of reticulocytosis. Mice were phlebotomized to ensure sufﬁcient
amount of reticulocytes for the experiments. Two-month old mice, both females
and males, were phlebotomized and 200–250 ml of blood was collected in 4 con-
secutive days from vena saphena. An equal volume of sterile 0.9% NaCl was given
intraperitoneally, as volume replacement after each phlebotomy. Haemoglobin was
monitored daily to monitor the anaemia level. On the ﬁfth day, the mice were killed
and blood was collected into EDTA tube by heart puncture.
Reticulocyte culture. Reticulocytes from EDTA blood were cultured as previously
reported52. In short, EDTA blood was diluted 1:500 in reticulocyte medium, plated
unto low attachment plates and maintained in a cell culture incubator with 5%
CO2, at 37 C for 4 days. Reticulocyte medium included 30% FBS, 0.001%
monothioglycerol (sc-213414, Santa Cruz), 1% deionized bovine serum albumin,
2mM glutamine, 100U penicillin and 0.1mgml 1 streptomycin in Iscove’s
Modiﬁed Dulbecco’s Medium (21980-032, Gibco). Cell culture grade reagents were
obtained from Sigma-Aldrich, if not otherwise noted.
N-acetyl-L-cysteine treatment. About 100mg kg 1 of NAC (A7250, Sigma-
Aldrich) was administered intraperitoneally after each phlebotomy, and 100 nM
NAC was added to the reticulocyte culture medium. In long-term NAC treatment,
study mice were given 1mgml 1 of N-acetyl-L-cysteine in drinking water during
pregnancy, lactation and continued for the pups after weaning throughout their
life. Only male mice were included in the long-term treatment and follow-up.
Analysis of mitochondrial clearance in reticulocytes. Cultured reticulocytes
were analyzed as previously described52. In short, Accuri ﬂow cytometer, nucleic
acid dye TO and MitoTracker Red (Molecular Probes) were used and 30,000 cells
per sample were analyzed. Cells were incubated in reticulocyte medium with
200 nM MitoTracker at 37 C for 20min, washed with PBS and suspended in PBS
with 2 mgml 1 thiazole orange and incubated for 40min, followed by two PBS
washes. Lasers and ﬁlters used for TO and MitoTracker Red detection were 488-nm
laser with 533/30-nm ﬁlter and 640-nm laser with 675/25-nm ﬁlter. Cells were also
stained with 500 nM MitoTracker Green, 1 mM TMRM (Molecular Probes), 60 nM
LysoTracker Red, anti-CD71 PE (553267, Beckton Dickinson, 1 mg per 1 106
cells) and anti-Ter119 FITC (11–5921–82, eBioscience, 1 mg per 1 106 cells) and
visualized using confocal microscope (Zeiss).
Total iron analysis. Serum/plasma total iron was analyzed using standard ferro-
zine method, but without deproteinization. In short, serum/plasma was diluted
with 100mM acetate buffer to reduce Fe(III) molecules to Fe(II) molecules, which
makes iron soluble. Ferrozine was added to ﬁnal concentration of 62.5 mM and
coloured complex formed by Fe(II) and ferrozine was measured by spectro-
photometer at wavelength 570 nm.
Transferrin analysis. Serum/plasma transferrin was analyzed using Abcam’s
Transferrin Mouse ELISA kit (ab157724) according to manufacturer’s instructions.
Transferrin saturation (%) was calculated by following formula: 3.825 iron
(mmol l 1) per transferrin (g l 1).
Plasma and intra-erythrocyte NPBI analysis. Plasma was diluted vol/vol in
distilled water and desferrioxamine (DFO, D9533, Sigma-Aldrich) was added
(25mM), followed by a 30-min incubation period at  80 C. After thawing at room
temperature, samples were ultraﬁltered at 3,400 g for 30min using centrifugal ﬁlters
with 30 kDa cut-off (Vivaspin 4, Sartorius Stedim Biotech GmbH). Ultraﬁltrate was
stored at  80 C until analysis. The DFO excess was removed by silica (silicagel;
25–40mm) column chromatography. The DFO–iron complex was determined by
HPLC, as previously reported24. In short, the ﬂow rate was 1.5mlmin 1 and the
pressure stabilized to 115–125 bars. Detection wavelength was 229 nm. Packed
erythrocytes were resuspended (vol/vol) in Ringer solution (125mM NaCl, 5mM
KCl, 1mM MgSO4, 32mM HEPES, 5mM glucose, 1mM CaCl2) pH 7.4 and
erythrocyte suspension was further diluted (vol/vol) with distilled water, followed by
addition of DFO and further treated similar to plasma samples.
Preparation of erythrocyte membranes (RBC ghosts). Packed erythrocytes were
lysed using buffer containing 5mM KH2PO4 and 0.78mM EDTA in pH 8.0 by
repeated resuspensions and centrifugations, resulting in pearly white membrane
fraction. Samples were stored at  80 C until analysis.
Western blot for 4-HNE protein adducts. About 30mg of protein (RBC ghosts
and plasma) were resolved on 10% SDS–PAGE gels and transferred onto a Hybond
ECL nitrocellulose membrane (Bio-Rad Laboratories). After blocking with 3% non-
fat milk, the membranes were incubated overnight at þ 4 C with goat polyclonal
anti 4-HNE antibody (1:3,000, AB5605, Millipore). After TBST washes, the mem-
branes were incubated with secondary antibody (1:10,000, rabbit anti-goat horse-
radish peroxidase conjugated, Sigma-Aldrich) and detected using enhanced
chemiluminescence reagents according to manufacturer’s instructions. Quantiﬁca-
tion of the bands was performed using ImageJ software. See Supplementary Fig. 4b,c
for all the original blots.
Analysis of PS exposure in erythrocytes. Packed erythrocytes were diluted 1:250
in Ringer solution and incubated with anti-Annexin V-FITC (ﬂuorescein
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isothiocyanate) in binding buffer (BD Pharmingen) according to manufacturer’s
instructions. Spleen cells were ﬁrst stained with anti-Ter119–PE (phycoerythrin)
(1mg per 1 106 cells), followed with Annexin V antibody (556420, Sigma-
Aldrich). Fluorescent signal was detected by Accuri ﬂow cytometer and 30,000 cells
per sample were analyzed.
Erythrocyte lifespan analysis. Survival of erythrocytes in vivo was determined
using in vivo biotinylation of erythrocytes and analysis of lifespan of the biotiny-
lated population by FACS analysis, exactly as described in ref. 53. In short, mice
were injected intravenously with 1mg of biotin (biotin-X-NHS, Merck Millipore)
for 3 consecutive days, and 0.6mg of biotin on the 8th day. Peripheral blood
samples were collected once a week for 3 weeks and stained with streptavidin–PE
(554061, BD Biosciences, 1 mg per 1 106 cells).
Flow cytometric analysis. Peripheral blood erythrocytes, reticulocytes and spleen
were analyzed by ﬂow cytometry. Conjugated antibodies against CD71 (TfR),
Ter119, CD45 (553081, BD Biosciences), CD47 (11-0471-82, e-Biosciences) and
mac3 (53-1072-82, e-Biosciences) were used as 1 mg per 1 106 cells after blocking
with anti-CD16/32 to prevent unspeciﬁc staining. MitoTracker Green was used to
visualize mitochondria and ﬂuorochrome-conjugated streptavidin for biotinylated
erythrocytes. Samples were analyzed using Accuri ﬂow cytometer and 30,000–
100,000 cells per sample were analyzed. The results were analyzed and visualized by
FlowJo data analysis software.
HSC extraction from bone marrow. Tibial and femoral bone marrows were
collected in DMEM (D6546, Sigma-Aldrich) from 11-month-old male mice and
forwarded directly to colony forming assay.
Haematopoietic colony forming assay. Presence of clonogenic hematopoietic
progenitors in the bone marrow was analyzed by culturing hematopoietic progenitors
in MethoCult (StemCell Technologies) for myelo-erythroid progenitors according to
manufacturer’s instructions. Triplicates were analyzed from each sample.
Preparation of histological samples. Spleens from 8-month-old males and
females and femoral bones from 11-month-old males were ﬁxed in formaldehyde
according to standard protocol. Bones were decalciﬁed in 10% EDTA prior to
tissue handling and parafﬁn embedding. Sections (3–5 mm) were cut in objective
slides for staining.
Perl’s Prussian Blue iron staining was used to detect iron accumulation in
spleen and bone marrow. Tissue sections were deparafﬁnized in xylene, followed by
descending ethanol series, aqua wash and 20min of incubation in 5% potassium
ferrocyanide in 10% HCl. Nuclear counterstain was performed using 0.1% nuclear
fast red Kernechtrot, followed by aqua wash, ascending ethanol series, xylene and
mounting.
Total protein extraction from erythrocytes. RIPA buffer (25mM Tris-HCl,
150mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, pH 7.5) supple-
mented with protease inhibitors (88665, Pierce) was used to extract total proteins
from packed and washed erythrocytes. Protein amount was not quantiﬁed, since
haemoglobin interferes with measurement techniques, but instead equal volume of
protein lysate from every sample was loaded to the gel.
Western blot analysis. Protein analysis was done using SDS–PAGE method with
precast 4–20% gradient gels (Bio-Rad) with semi-dry blotting to PVDF (poly-
vinylidene diﬂuoride) membrane (IPVH00010, Millipore). The membrane was
blocked for 1 hour with 1% milk in TBST (Tris-buffered saline and Tween 20), and
primary antibodies (anti-BNIP3L/NIX 1:2,000, #2289 ProSci and anti-GAPDH
1:2,000, #2118 Cell Signaling Technology) were incubated overnight at 4 C.
Horseradish peroxidase-conjugated secondary antibody (Pierce) was incubated for
1 hour at room temperature, followed by detection using ECL reagents according
to manufacturer’s instructions (#32132 Pierce). Samples were analyzed using
Chemidoc (Bio-Rad) and NIX signal was normalized against GAPDH. See
Supplementary Fig. 4a for all the blots.
Statistical analysis. Student’s t-test was used to calculate the statistical sig-
niﬁcance of the results, and two-tailed Po0.05 was considered signiﬁcant. Data are
represented as mean±s.d., and two-tailed P values are shown in ﬁgures as asterisks
as follows: *Po0.05, **Po0.01, ***Po0.001 and ****Po0.0001. Linear regression
analysis was used to analyze statistical signiﬁcance of the difference of the slopes in
BFU-E maturation and erythrocyte lifespan assay.
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